skip to main content
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Mostrar Somente
Refinado por: Base de dados/Biblioteca: North East Research Libraries Nature Academic Titles remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Aberrant cytokine signaling in leukemia
Material Type:
Artigo
Adicionar ao Meu Espaço

Aberrant cytokine signaling in leukemia

Van Etten, R A

Oncogene, 2007-10, Vol.26 (47), p.6738-6749 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

2
Aberrant expression of CD123 (interleukin-3 receptor-α) on neoplastic mast cells
Material Type:
Artigo
Adicionar ao Meu Espaço

Aberrant expression of CD123 (interleukin-3 receptor-α) on neoplastic mast cells

Pardanani, A ; Lasho, T ; Chen, D ; Kimlinger, T K ; Finke, C ; Zblewski, D ; Patnaik, M M ; Reichard, K K ; Rowinsky, E ; Hanson, C A ; Brooks, C ; Tefferi, A

Leukemia, 2015-07, Vol.29 (7), p.1605-1608 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

3
ABO, alemtuzumab and allogeneic transplantation
Material Type:
Artigo
Adicionar ao Meu Espaço

ABO, alemtuzumab and allogeneic transplantation

Cooling, L

Bone marrow transplantation (Basingstoke), 2015-07, Vol.50 (7), p.881-883 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

4
ABO, alemtuzumab and allogeneic transplantation: this article has been corrected since Advance Online Publication and a corrigendum is also printed in this issue
Material Type:
Artigo
Adicionar ao Meu Espaço

ABO, alemtuzumab and allogeneic transplantation: this article has been corrected since Advance Online Publication and a corrigendum is also printed in this issue

Cooling, L

Bone marrow transplantation (Basingstoke), 2015-07, Vol.50 (7), p.881 [Periódico revisado por pares]

Nature Publishing Group

Texto completo disponível

5
Achievement of a negative minimal residual disease state after hypomethylating agent therapy in older patients with AML reduces the risk of relapse
Material Type:
Artigo
Adicionar ao Meu Espaço

Achievement of a negative minimal residual disease state after hypomethylating agent therapy in older patients with AML reduces the risk of relapse

Boddu, P ; Jorgensen, J ; Kantarjian, H ; Borthakur, G ; Kadia, T ; Daver, N ; Alvarado, Y ; Pemmaraju, N ; Bose, P ; Naqvi, K ; Yilmaz, M ; Pierce, S ; Brandt, M ; DiNardo, C D ; Jabbour, E J ; Konopleva, M ; Garcia-Manero, G ; Cortes, J ; Ravandi, F

Leukemia, 2018-01, Vol.32 (1), p.241-244 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

6
Activation of the NF- B pathway by the leukemogenic TEL-Jak2 and TEL-Abl fusion proteins leads to the accumulation of antiapoptotic IAP proteins and involves IKK
Material Type:
Artigo
Adicionar ao Meu Espaço

Activation of the NF- B pathway by the leukemogenic TEL-Jak2 and TEL-Abl fusion proteins leads to the accumulation of antiapoptotic IAP proteins and involves IKK

Malinge, S ; Monni, R ; Bernard, O ; Penard-Lacronique, V

Oncogene, 2006-06, Vol.25 (25), p.3589-3597 [Periódico revisado por pares]

New York: Nature Publishing Group

Texto completo disponível

7
Activation of the NF-κB pathway by the leukemogenic TEL-Jak2 and TEL-Abl fusion proteins leads to the accumulation of antiapoptotic IAP proteins and involves IKKα
Material Type:
Artigo
Adicionar ao Meu Espaço

Activation of the NF-κB pathway by the leukemogenic TEL-Jak2 and TEL-Abl fusion proteins leads to the accumulation of antiapoptotic IAP proteins and involves IKKα

MALINGE, S ; MONNI, R ; BERNARD, O ; PENARD-LACRONIQUE, V

Oncogene, 2006-06, Vol.25 (25), p.3589-3597 [Periódico revisado por pares]

Basingstoke: Nature Publishing

Texto completo disponível

8
Adding bendamustine to melphalan before ASCT improves CR rate in myeloma vs. melphalan alone: A randomized phase-2 trial
Material Type:
Artigo
Adicionar ao Meu Espaço

Adding bendamustine to melphalan before ASCT improves CR rate in myeloma vs. melphalan alone: A randomized phase-2 trial

Farag, Sarah ; Bacher, Ulrike ; Jeker, Barbara ; Legros, Myriam ; Rhyner, Gaelle ; Lüthi, Jean-Marc ; Schardt, Julian ; Zander, Thilo ; Daskalakis, Michael ; Mansouri, Behrouz ; Manz, Chantal ; Pabst, Thomas

Bone marrow transplantation (Basingstoke), 2022-06, Vol.57 (6), p.990-997 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

9
Adipogenesis of skeletal muscle fibro/adipogenic progenitors is affected by the WNT5a/GSK3/β-catenin axis
Material Type:
Artigo
Adicionar ao Meu Espaço

Adipogenesis of skeletal muscle fibro/adipogenic progenitors is affected by the WNT5a/GSK3/β-catenin axis

Reggio, Alessio ; Rosina, Marco ; Palma, Alessandro ; Cerquone Perpetuini, Andrea ; Petrilli, Lucia Lisa ; Gargioli, Cesare ; Fuoco, Claudia ; Micarelli, Elisa ; Giuliani, Giulio ; Cerretani, Mauro ; Bresciani, Alberto ; Sacco, Francesca ; Castagnoli, Luisa ; Cesareni, Gianni

Cell death and differentiation, 2020-10, Vol.27 (10), p.2921-2941 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

10
Adult umbilical cord blood transplantation: a comprehensive review
Material Type:
Artigo
Adicionar ao Meu Espaço

Adult umbilical cord blood transplantation: a comprehensive review

SCHOEMANS, H ; THEUNISSEN, K ; MAERTENS, J ; BOOGAERTS, M ; VERFAILLIE, C ; WAGNER, J

Bone marrow transplantation (Basingstoke), 2006-07, Vol.38 (2), p.83-93 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (394)

Data de Publicação 

De até
  1. Antes de2002  (17)
  2. 2002Até2006  (61)
  3. 2007Até2011  (109)
  4. 2012Até2017  (112)
  5. Após 2017  (97)
  6. Mais opções open sub menu

Buscando em bases de dados remotas. Favor aguardar.